Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Oncimmune expands access to cancer risk lung, liver blood tests on December 29, 2018 at 6:37 am
Oncimmune Holdings entered into an agreement with America’s Choice Provider Network to expand access to the company’s EarlyCDT-Lung and EarlyCDT-Liver blood tests, designed to assess cancer risks, acc... […]
- Five Things To Look Out For In Cancer Research In 2019 on December 28, 2018 at 11:53 am
The promise is that eventually, we should be able to diagnose cancer with a simple blood test, earlier, more cheaply and even more accurately than we currently do and even use these tests to monitor r... […]
- Instead of a blood test, researchers developed an app on your phone to detect anemia on December 27, 2018 at 8:18 am
This is a non-invasive way to test for anemia — a condition in which you don't ... a clinical hematologist-bioengineer at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlant... […]
- Should You Get Screened for Prostate Cancer? on December 26, 2018 at 10:00 am
It has been an important screening blood test, but it can result in false positives. That’s because there are several issues that can directly influence PSA, not just cancer—such as infection, irritat... […]
- Bile Duct Cancer Market visualized increasing with 9.2 % CAGR between 2018 and 2023 on December 26, 2018 at 5:07 am
The global bile duct cancer market is expected to grow at an approximate CAGR ... On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagn... […]
- I Was Diagnosed with an Aggressive Blood Cancer During My Honeymoon on December 24, 2018 at 6:32 am
The blood cancer is rare, affecting less than 20,000 new people every ... In that first year [of marriage], we put every single word of our vows to the test,' says Matt. 'It was such a powerful, galva... […]
- Groundbreaking Research In 2018 That Furthered The Study Of Alzheimer's, Cancer And Blood Pressure on December 21, 2018 at 10:34 am
Funded in part by the NIH’s National Cancer Institute (NCI) and the National Institute of General Medical Sciences (NIGMS), researchers worked to develop tests that detect bits of tumor material in bo... […]
- Holiday Blood Drive: One West Fargo Couple’s Story About Giving and Receiving on December 21, 2018 at 5:48 am
But after being told to take a deep breath and fighting her first battle, 5 ½ years later Tami was re–diagnosed with the same cancer. “Tim pushes me to get a blood test, it’s hard to just push myself ... […]
- Important Things to Know About Your Prostate Cancer Diagnosis on December 21, 2018 at 5:12 am
Decisions during the initial steps of a cancer diagnosis can be the most important ... We looked at my past and current PSA blood tests (prostate–specific antigen) numbers and saw an increase to 2.85 ... […]
- New testing recommendations for prostate cancer on December 20, 2018 at 8:50 am
A new study of more than 400,000 men in Elsevier’s Urology Journal suggests that a yearly blood test for prostate cancer could reduce prostate cancer deaths by 64 percent for men aged 55 to 75 years. ... […]
via Bing News